 | • レポートコード：MRC2-11QY00820 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はサイクリン依存性キナーゼ1のグローバル市場について調査・分析したレポートです。種類別（AT-7519、CD-650、Milciclib、その他）市場規模、用途別（再発性慢性リンパ性白血病、神経膠肉腫、リンパ腫、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別サイクリン依存性キナーゼ1の競争状況、市場シェア ・世界のサイクリン依存性キナーゼ1市場：種類別市場規模 2015年-2020年（AT-7519、CD-650、Milciclib、その他） ・世界のサイクリン依存性キナーゼ1市場：種類別市場規模予測 2021年-2026年（AT-7519、CD-650、Milciclib、その他） ・世界のサイクリン依存性キナーゼ1市場：用途別市場規模 2015年-2020年（再発性慢性リンパ性白血病、神経膠肉腫、リンパ腫、その他） ・世界のサイクリン依存性キナーゼ1市場：用途別市場規模予測 2021年-2026年（再発性慢性リンパ性白血病、神経膠肉腫、リンパ腫、その他） ・北米のサイクリン依存性キナーゼ1市場分析：米国、カナダ ・ヨーロッパのサイクリン依存性キナーゼ1市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのサイクリン依存性キナーゼ1市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のサイクリン依存性キナーゼ1市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのサイクリン依存性キナーゼ1市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Astex Pharmaceuticals Inc、ChoDang Pharm Co Ltd、Presage Biosciences Inc、Tiziana Life Sciences Plc、Tragara Pharmaceuticals Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Cyclin Dependent Kinase 1 Market
The global Cyclin Dependent Kinase 1 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Cyclin Dependent Kinase 1 Scope and Market Size
Cyclin Dependent Kinase 1 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cyclin Dependent Kinase 1 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Cyclin Dependent Kinase 1 market is segmented into
AT-7519
CD-650
Milciclib
Others
Segment by Application, the Cyclin Dependent Kinase 1 market is segmented into
Relapsed Chronic Lymphocytic Leukemia
Gliosarcoma
Lymphoma
Others
Regional and Country-level Analysis
The Cyclin Dependent Kinase 1 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cyclin Dependent Kinase 1 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cyclin Dependent Kinase 1 Market Share Analysis
Cyclin Dependent Kinase 1 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cyclin Dependent Kinase 1 business, the date to enter into the Cyclin Dependent Kinase 1 market, Cyclin Dependent Kinase 1 product introduction, recent developments, etc.
The major vendors covered:
Astex Pharmaceuticals Inc
ChoDang Pharm Co Ltd
Presage Biosciences Inc
Tiziana Life Sciences Plc
Tragara Pharmaceuticals Inc
…
1 Study Coverage
1.1 Cyclin Dependent Kinase 1 Product Introduction
1.2 Market Segments
1.3 Key Cyclin Dependent Kinase 1 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cyclin Dependent Kinase 1 Market Size Growth Rate by Type
1.4.2 AT-7519
1.4.3 CD-650
1.4.4 Milciclib
1.4.5 Others
1.5 Market by Application
1.5.1 Global Cyclin Dependent Kinase 1 Market Size Growth Rate by Application
1.5.2 Relapsed Chronic Lymphocytic Leukemia
1.5.3 Gliosarcoma
1.5.4 Lymphoma
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cyclin Dependent Kinase 1 Market Size, Estimates and Forecasts
2.1.1 Global Cyclin Dependent Kinase 1 Revenue 2015-2026
2.1.2 Global Cyclin Dependent Kinase 1 Sales 2015-2026
2.2 Global Cyclin Dependent Kinase 1, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Cyclin Dependent Kinase 1 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Cyclin Dependent Kinase 1 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Cyclin Dependent Kinase 1 Competitor Landscape by Players
3.1 Cyclin Dependent Kinase 1 Sales by Manufacturers
3.1.1 Cyclin Dependent Kinase 1 Sales by Manufacturers (2015-2020)
3.1.2 Cyclin Dependent Kinase 1 Sales Market Share by Manufacturers (2015-2020)
3.2 Cyclin Dependent Kinase 1 Revenue by Manufacturers
3.2.1 Cyclin Dependent Kinase 1 Revenue by Manufacturers (2015-2020)
3.2.2 Cyclin Dependent Kinase 1 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cyclin Dependent Kinase 1 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cyclin Dependent Kinase 1 Revenue in 2019
3.2.5 Global Cyclin Dependent Kinase 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Cyclin Dependent Kinase 1 Price by Manufacturers
3.4 Cyclin Dependent Kinase 1 Manufacturing Base Distribution, Product Types
3.4.1 Cyclin Dependent Kinase 1 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cyclin Dependent Kinase 1 Product Type
3.4.3 Date of International Manufacturers Enter into Cyclin Dependent Kinase 1 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cyclin Dependent Kinase 1 Market Size by Type (2015-2020)
4.1.1 Global Cyclin Dependent Kinase 1 Sales by Type (2015-2020)
4.1.2 Global Cyclin Dependent Kinase 1 Revenue by Type (2015-2020)
4.1.3 Cyclin Dependent Kinase 1 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cyclin Dependent Kinase 1 Market Size Forecast by Type (2021-2026)
4.2.1 Global Cyclin Dependent Kinase 1 Sales Forecast by Type (2021-2026)
4.2.2 Global Cyclin Dependent Kinase 1 Revenue Forecast by Type (2021-2026)
4.2.3 Cyclin Dependent Kinase 1 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cyclin Dependent Kinase 1 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Cyclin Dependent Kinase 1 Market Size by Application (2015-2020)
5.1.1 Global Cyclin Dependent Kinase 1 Sales by Application (2015-2020)
5.1.2 Global Cyclin Dependent Kinase 1 Revenue by Application (2015-2020)
5.1.3 Cyclin Dependent Kinase 1 Price by Application (2015-2020)
5.2 Cyclin Dependent Kinase 1 Market Size Forecast by Application (2021-2026)
5.2.1 Global Cyclin Dependent Kinase 1 Sales Forecast by Application (2021-2026)
5.2.2 Global Cyclin Dependent Kinase 1 Revenue Forecast by Application (2021-2026)
5.2.3 Global Cyclin Dependent Kinase 1 Price Forecast by Application (2021-2026)
6 North America
6.1 North America Cyclin Dependent Kinase 1 by Country
6.1.1 North America Cyclin Dependent Kinase 1 Sales by Country
6.1.2 North America Cyclin Dependent Kinase 1 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Cyclin Dependent Kinase 1 Market Facts & Figures by Type
6.3 North America Cyclin Dependent Kinase 1 Market Facts & Figures by Application
7 Europe
7.1 Europe Cyclin Dependent Kinase 1 by Country
7.1.1 Europe Cyclin Dependent Kinase 1 Sales by Country
7.1.2 Europe Cyclin Dependent Kinase 1 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cyclin Dependent Kinase 1 Market Facts & Figures by Type
7.3 Europe Cyclin Dependent Kinase 1 Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Cyclin Dependent Kinase 1 by Region
8.1.1 Asia Pacific Cyclin Dependent Kinase 1 Sales by Region
8.1.2 Asia Pacific Cyclin Dependent Kinase 1 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Cyclin Dependent Kinase 1 Market Facts & Figures by Type
8.3 Asia Pacific Cyclin Dependent Kinase 1 Market Facts & Figures by Application
9 Latin America
9.1 Latin America Cyclin Dependent Kinase 1 by Country
9.1.1 Latin America Cyclin Dependent Kinase 1 Sales by Country
9.1.2 Latin America Cyclin Dependent Kinase 1 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Cyclin Dependent Kinase 1 Market Facts & Figures by Type
9.3 Central & South America Cyclin Dependent Kinase 1 Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Cyclin Dependent Kinase 1 by Country
10.1.1 Middle East and Africa Cyclin Dependent Kinase 1 Sales by Country
10.1.2 Middle East and Africa Cyclin Dependent Kinase 1 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Cyclin Dependent Kinase 1 Market Facts & Figures by Type
10.3 Middle East and Africa Cyclin Dependent Kinase 1 Market Facts & Figures by Application
11 Company Profiles
11.1 Astex Pharmaceuticals Inc
11.1.1 Astex Pharmaceuticals Inc Corporation Information
11.1.2 Astex Pharmaceuticals Inc Description and Business Overview
11.1.3 Astex Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Products Offered
11.1.5 Astex Pharmaceuticals Inc Related Developments
11.2 ChoDang Pharm Co Ltd
11.2.1 ChoDang Pharm Co Ltd Corporation Information
11.2.2 ChoDang Pharm Co Ltd Description and Business Overview
11.2.3 ChoDang Pharm Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.2.4 ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Products Offered
11.2.5 ChoDang Pharm Co Ltd Related Developments
11.3 Presage Biosciences Inc
11.3.1 Presage Biosciences Inc Corporation Information
11.3.2 Presage Biosciences Inc Description and Business Overview
11.3.3 Presage Biosciences Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Presage Biosciences Inc Cyclin Dependent Kinase 1 Products Offered
11.3.5 Presage Biosciences Inc Related Developments
11.4 Tiziana Life Sciences Plc
11.4.1 Tiziana Life Sciences Plc Corporation Information
11.4.2 Tiziana Life Sciences Plc Description and Business Overview
11.4.3 Tiziana Life Sciences Plc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Products Offered
11.4.5 Tiziana Life Sciences Plc Related Developments
11.5 Tragara Pharmaceuticals Inc
11.5.1 Tragara Pharmaceuticals Inc Corporation Information
11.5.2 Tragara Pharmaceuticals Inc Description and Business Overview
11.5.3 Tragara Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Products Offered
11.5.5 Tragara Pharmaceuticals Inc Related Developments
11.1 Astex Pharmaceuticals Inc
11.1.1 Astex Pharmaceuticals Inc Corporation Information
11.1.2 Astex Pharmaceuticals Inc Description and Business Overview
11.1.3 Astex Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Products Offered
11.1.5 Astex Pharmaceuticals Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Cyclin Dependent Kinase 1 Market Estimates and Projections by Region
12.1.1 Global Cyclin Dependent Kinase 1 Sales Forecast by Regions 2021-2026
12.1.2 Global Cyclin Dependent Kinase 1 Revenue Forecast by Regions 2021-2026
12.2 North America Cyclin Dependent Kinase 1 Market Size Forecast (2021-2026)
12.2.1 North America: Cyclin Dependent Kinase 1 Sales Forecast (2021-2026)
12.2.2 North America: Cyclin Dependent Kinase 1 Revenue Forecast (2021-2026)
12.2.3 North America: Cyclin Dependent Kinase 1 Market Size Forecast by Country (2021-2026)
12.3 Europe Cyclin Dependent Kinase 1 Market Size Forecast (2021-2026)
12.3.1 Europe: Cyclin Dependent Kinase 1 Sales Forecast (2021-2026)
12.3.2 Europe: Cyclin Dependent Kinase 1 Revenue Forecast (2021-2026)
12.3.3 Europe: Cyclin Dependent Kinase 1 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Cyclin Dependent Kinase 1 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Cyclin Dependent Kinase 1 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Cyclin Dependent Kinase 1 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Cyclin Dependent Kinase 1 Market Size Forecast by Region (2021-2026)
12.5 Latin America Cyclin Dependent Kinase 1 Market Size Forecast (2021-2026)
12.5.1 Latin America: Cyclin Dependent Kinase 1 Sales Forecast (2021-2026)
12.5.2 Latin America: Cyclin Dependent Kinase 1 Revenue Forecast (2021-2026)
12.5.3 Latin America: Cyclin Dependent Kinase 1 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Cyclin Dependent Kinase 1 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Cyclin Dependent Kinase 1 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Cyclin Dependent Kinase 1 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Cyclin Dependent Kinase 1 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Cyclin Dependent Kinase 1 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cyclin Dependent Kinase 1 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Cyclin Dependent Kinase 1 Market Segments
Table 2. Ranking of Global Top Cyclin Dependent Kinase 1 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Cyclin Dependent Kinase 1 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AT-7519
Table 5. Major Manufacturers of CD-650
Table 6. Major Manufacturers of Milciclib
Table 7. Major Manufacturers of Others
Table 8. Global Cyclin Dependent Kinase 1 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Cyclin Dependent Kinase 1 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Cyclin Dependent Kinase 1 Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Cyclin Dependent Kinase 1 Sales Market Share by Regions (2015-2020)
Table 12. Global Cyclin Dependent Kinase 1 Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Cyclin Dependent Kinase 1 Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Cyclin Dependent Kinase 1 Sales Share by Manufacturers (2015-2020)
Table 15. Global Cyclin Dependent Kinase 1 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Cyclin Dependent Kinase 1 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyclin Dependent Kinase 1 as of 2019)
Table 17. Cyclin Dependent Kinase 1 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Cyclin Dependent Kinase 1 Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Cyclin Dependent Kinase 1 Price (2015-2020) (USD/Pcs)
Table 20. Cyclin Dependent Kinase 1 Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Cyclin Dependent Kinase 1 Product Type
Table 22. Date of International Manufacturers Enter into Cyclin Dependent Kinase 1 Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Cyclin Dependent Kinase 1 Sales by Type (2015-2020) (K Pcs)
Table 25. Global Cyclin Dependent Kinase 1 Sales Share by Type (2015-2020)
Table 26. Global Cyclin Dependent Kinase 1 Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Cyclin Dependent Kinase 1 Revenue Share by Type (2015-2020)
Table 28. Cyclin Dependent Kinase 1 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Cyclin Dependent Kinase 1 Sales by Application (2015-2020) (K Pcs)
Table 30. Global Cyclin Dependent Kinase 1 Sales Share by Application (2015-2020)
Table 31. North America Cyclin Dependent Kinase 1 Sales by Country (2015-2020) (K Pcs)
Table 32. North America Cyclin Dependent Kinase 1 Sales Market Share by Country (2015-2020)
Table 33. North America Cyclin Dependent Kinase 1 Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Cyclin Dependent Kinase 1 Revenue Market Share by Country (2015-2020)
Table 35. North America Cyclin Dependent Kinase 1 Sales by Type (2015-2020) (K Pcs)
Table 36. North America Cyclin Dependent Kinase 1 Sales Market Share by Type (2015-2020)
Table 37. North America Cyclin Dependent Kinase 1 Sales by Application (2015-2020) (K Pcs)
Table 38. North America Cyclin Dependent Kinase 1 Sales Market Share by Application (2015-2020)
Table 39. Europe Cyclin Dependent Kinase 1 Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Cyclin Dependent Kinase 1 Sales Market Share by Country (2015-2020)
Table 41. Europe Cyclin Dependent Kinase 1 Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Cyclin Dependent Kinase 1 Revenue Market Share by Country (2015-2020)
Table 43. Europe Cyclin Dependent Kinase 1 Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Cyclin Dependent Kinase 1 Sales Market Share by Type (2015-2020)
Table 45. Europe Cyclin Dependent Kinase 1 Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Cyclin Dependent Kinase 1 Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Cyclin Dependent Kinase 1 Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Cyclin Dependent Kinase 1 Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Cyclin Dependent Kinase 1 Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Cyclin Dependent Kinase 1 Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Cyclin Dependent Kinase 1 Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Cyclin Dependent Kinase 1 Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Cyclin Dependent Kinase 1 Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Cyclin Dependent Kinase 1 Sales Market Share by Application (2015-2020)
Table 55. Latin America Cyclin Dependent Kinase 1 Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Cyclin Dependent Kinase 1 Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Cyclin Dependent Kinase 1 Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Cyclin Dependent Kinase 1 Revenue Market Share by Country (2015-2020)
Table 59. Latin America Cyclin Dependent Kinase 1 Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Cyclin Dependent Kinase 1 Sales Market Share by Type (2015-2020)
Table 61. Latin America Cyclin Dependent Kinase 1 Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Cyclin Dependent Kinase 1 Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Cyclin Dependent Kinase 1 Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Cyclin Dependent Kinase 1 Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Cyclin Dependent Kinase 1 Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Cyclin Dependent Kinase 1 Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Cyclin Dependent Kinase 1 Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Cyclin Dependent Kinase 1 Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Cyclin Dependent Kinase 1 Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Cyclin Dependent Kinase 1 Sales Market Share by Application (2015-2020)
Table 71. Astex Pharmaceuticals Inc Corporation Information
Table 72. Astex Pharmaceuticals Inc Description and Major Businesses
Table 73. Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Astex Pharmaceuticals Inc Product
Table 75. Astex Pharmaceuticals Inc Recent Development
Table 76. ChoDang Pharm Co Ltd Corporation Information
Table 77. ChoDang Pharm Co Ltd Description and Major Businesses
Table 78. ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. ChoDang Pharm Co Ltd Product
Table 80. ChoDang Pharm Co Ltd Recent Development
Table 81. Presage Biosciences Inc Corporation Information
Table 82. Presage Biosciences Inc Description and Major Businesses
Table 83. Presage Biosciences Inc Cyclin Dependent Kinase 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Presage Biosciences Inc Product
Table 85. Presage Biosciences Inc Recent Development
Table 86. Tiziana Life Sciences Plc Corporation Information
Table 87. Tiziana Life Sciences Plc Description and Major Businesses
Table 88. Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Tiziana Life Sciences Plc Product
Table 90. Tiziana Life Sciences Plc Recent Development
Table 91. Tragara Pharmaceuticals Inc Corporation Information
Table 92. Tragara Pharmaceuticals Inc Description and Major Businesses
Table 93. Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Tragara Pharmaceuticals Inc Product
Table 95. Tragara Pharmaceuticals Inc Recent Development
Table 96. Global Cyclin Dependent Kinase 1 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 97. Global Cyclin Dependent Kinase 1 Sales Market Share Forecast by Regions (2021-2026)
Table 98. Global Cyclin Dependent Kinase 1 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 99. Global Cyclin Dependent Kinase 1 Revenue Market Share Forecast by Regions (2021-2026)
Table 100. North America: Cyclin Dependent Kinase 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 101. North America: Cyclin Dependent Kinase 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 102. Europe: Cyclin Dependent Kinase 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 103. Europe: Cyclin Dependent Kinase 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Asia Pacific: Cyclin Dependent Kinase 1 Sales Forecast by Region (2021-2026) (K Pcs)
Table 105. Asia Pacific: Cyclin Dependent Kinase 1 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 106. Latin America: Cyclin Dependent Kinase 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 107. Latin America: Cyclin Dependent Kinase 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Middle East and Africa: Cyclin Dependent Kinase 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 109. Middle East and Africa: Cyclin Dependent Kinase 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 111. Key Challenges
Table 112. Market Risks
Table 113. Main Points Interviewed from Key Cyclin Dependent Kinase 1 Players
Table 114. Cyclin Dependent Kinase 1 Customers List
Table 115. Cyclin Dependent Kinase 1 Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Cyclin Dependent Kinase 1 Product Picture
Figure 2. Global Cyclin Dependent Kinase 1 Sales Market Share by Type in 2020 & 2026
Figure 3. AT-7519 Product Picture
Figure 4. CD-650 Product Picture
Figure 5. Milciclib Product Picture
Figure 6. Others Product Picture
Figure 7. Global Cyclin Dependent Kinase 1 Sales Market Share by Application in 2020 & 2026
Figure 8. Relapsed Chronic Lymphocytic Leukemia
Figure 9. Gliosarcoma
Figure 10. Lymphoma
Figure 11. Others
Figure 12. Cyclin Dependent Kinase 1 Report Years Considered
Figure 13. Global Cyclin Dependent Kinase 1 Market Size 2015-2026 (US$ Million)
Figure 14. Global Cyclin Dependent Kinase 1 Sales 2015-2026 (K Pcs)
Figure 15. Global Cyclin Dependent Kinase 1 Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Cyclin Dependent Kinase 1 Sales Market Share by Region (2015-2020)
Figure 17. Global Cyclin Dependent Kinase 1 Sales Market Share by Region in 2019
Figure 18. Global Cyclin Dependent Kinase 1 Revenue Market Share by Region (2015-2020)
Figure 19. Global Cyclin Dependent Kinase 1 Revenue Market Share by Region in 2019
Figure 20. Global Cyclin Dependent Kinase 1 Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Cyclin Dependent Kinase 1 Revenue in 2019
Figure 22. Cyclin Dependent Kinase 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Cyclin Dependent Kinase 1 Sales Market Share by Type (2015-2020)
Figure 24. Global Cyclin Dependent Kinase 1 Sales Market Share by Type in 2019
Figure 25. Global Cyclin Dependent Kinase 1 Revenue Market Share by Type (2015-2020)
Figure 26. Global Cyclin Dependent Kinase 1 Revenue Market Share by Type in 2019
Figure 27. Global Cyclin Dependent Kinase 1 Market Share by Price Range (2015-2020)
Figure 28. Global Cyclin Dependent Kinase 1 Sales Market Share by Application (2015-2020)
Figure 29. Global Cyclin Dependent Kinase 1 Sales Market Share by Application in 2019
Figure 30. Global Cyclin Dependent Kinase 1 Revenue Market Share by Application (2015-2020)
Figure 31. Global Cyclin Dependent Kinase 1 Revenue Market Share by Application in 2019
Figure 32. North America Cyclin Dependent Kinase 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Cyclin Dependent Kinase 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Cyclin Dependent Kinase 1 Sales Market Share by Country in 2019
Figure 35. North America Cyclin Dependent Kinase 1 Revenue Market Share by Country in 2019
Figure 36. U.S. Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Cyclin Dependent Kinase 1 Market Share by Type in 2019
Figure 41. North America Cyclin Dependent Kinase 1 Market Share by Application in 2019
Figure 42. Europe Cyclin Dependent Kinase 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Cyclin Dependent Kinase 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Cyclin Dependent Kinase 1 Sales Market Share by Country in 2019
Figure 45. Europe Cyclin Dependent Kinase 1 Revenue Market Share by Country in 2019
Figure 46. Germany Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Cyclin Dependent Kinase 1 Market Share by Type in 2019
Figure 57. Europe Cyclin Dependent Kinase 1 Market Share by Application in 2019
Figure 58. Asia Pacific Cyclin Dependent Kinase 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Cyclin Dependent Kinase 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Cyclin Dependent Kinase 1 Sales Market Share by Region in 2019
Figure 61. Asia Pacific Cyclin Dependent Kinase 1 Revenue Market Share by Region in 2019
Figure 62. China Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Cyclin Dependent Kinase 1 Market Share by Type in 2019
Figure 85. Asia Pacific Cyclin Dependent Kinase 1 Market Share by Application in 2019
Figure 86. Latin America Cyclin Dependent Kinase 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Cyclin Dependent Kinase 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Cyclin Dependent Kinase 1 Sales Market Share by Country in 2019
Figure 89. Latin America Cyclin Dependent Kinase 1 Revenue Market Share by Country in 2019
Figure 90. Mexico Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Cyclin Dependent Kinase 1 Market Share by Type in 2019
Figure 97. Latin America Cyclin Dependent Kinase 1 Market Share by Application in 2019
Figure 98. Middle East and Africa Cyclin Dependent Kinase 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Cyclin Dependent Kinase 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Cyclin Dependent Kinase 1 Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Cyclin Dependent Kinase 1 Revenue Market Share by Country in 2019
Figure 102. Turkey Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Cyclin Dependent Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Cyclin Dependent Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Cyclin Dependent Kinase 1 Market Share by Type in 2019
Figure 109. Middle East and Africa Cyclin Dependent Kinase 1 Market Share by Application in 2019
Figure 110. North America Cyclin Dependent Kinase 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Cyclin Dependent Kinase 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Cyclin Dependent Kinase 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Cyclin Dependent Kinase 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Cyclin Dependent Kinase 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Cyclin Dependent Kinase 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Cyclin Dependent Kinase 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Cyclin Dependent Kinase 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Cyclin Dependent Kinase 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Cyclin Dependent Kinase 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
サイクリン依存性キナーゼ7の世界市場（～2026年） Market Analysis and Insights: Global Cyclin Dependent Kinase 7 Market The global Cyclin Dependent Kinase 7 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cyclin Dependent Kinase 7 Scope and Market Size Cyclin Dependen…- サイクリン依存性キナーゼ9の世界市場（～2026年） Market Analysis and Insights: Global Cyclin Dependent Kinase 9 Market The global Cyclin Dependent Kinase 9 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cyclin Dependent Kinase 9 Scope and Market Size Cyclin Dependen…
- サイクリン依存性キナーゼ6の世界市場（～2026年） Market Analysis and Insights: Global Cyclin Dependent Kinase 6 Market The global Cyclin Dependent Kinase 6 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cyclin Dependent Kinase 6 Scope and Market Size Cyclin Dependen…
- 3ホスホイノシチド依存性プロテインキナーゼ1の世界市場（～2026年） Market Analysis and Insights: Global 3 Phosphoinositide Dependent Protein Kinase 1 Market The global 3 Phosphoinositide Dependent Protein Kinase 1 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global 3 Phosphoinositide Depe…
- グルコース依存性インスリン分泌性受容体の世界市場（～2026年） Market Analysis and Insights: Global Glucose Dependent Insulinotropic Receptor Market The global Glucose Dependent Insulinotropic Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Glucose Dependent Insulinotropi…